CDY 1.43% 7.1¢ cellmid limited

2018 - The Year of the BioTechs, page-9

  1. 1,750 Posts.
    lightbulb Created with Sketch. 132
    Looking at last years Half Yearly report of Late February 2017, there was a comprehensive summary of the Cellmid operation and its constituent parts.
    I look forward to this years HY in the coming weeks where there will no doubt be some excellent news.
    Dont really expect to hear much in the interim but if the SP wants to go berserk in anticipation that fine with me.
    Last edited by Pharmargeddon: 14/02/18
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.